"For those of us who study rare diseases, genome sequencing is nothing short of revolutionary," says James Evans, M.D., who directs the Clinical Adult and Cancer Genetics Services at the University of North Carolina and also edits the journal Genetics in Medicine. "But as someone who also practices general medicine, I wouldn't yet call it revolutionary in a real-world sense." Evans thinks all providers should be aware of situations where genome sequencing and related testing would be useful, and identify an appropriate lab to do those tests, even if the volume is fairly low at the moment.
All Health Data Management articles are archived after 7 days. REGISTER NOW for unlimited access to all recently archived articles, as well as thousands of searchable stories. Registered Members also gain access to exclusive industry white paper downloads, web seminars, podcasts, e-books, and conference discounts. Qualified members may also choose to receive our free monthly magazine and any of our e-newsletters covering the latest breaking news, opinions from industry leaders, developing trends and specialized topics like EHR's, revenue cycle management, health insurance exchanges, analytics, and more!